- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPOQuarterly Results
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.8 | 1.92 |
NAV | ₹526.30 | ₹441.91 |
Fund Started | 10 May 2004 | 04 Jun 1999 |
Fund Size | ₹8569.15 Cr | ₹3849.24 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.8
1.92
NAV
₹526.30
₹441.91
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8569.15 Cr
₹3849.24 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 13.07% | 19.84% |
3 Year | 24.53% | 28.42% |
5 Year | 21.59% | 23.67% |
1 Year
13.07%
19.84%
3 Year
24.53%
28.42%
5 Year
21.59%
23.67%
Holding Analysis
Equity | 99.43% | 96.98% |
Cash | 0.57% | 2.94% |
Equity
99.43%
96.98%
Cash
0.57%
2.94%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.23% |
Divi's Laboratories Ltd. | 8.50% |
Lupin Ltd. | 6.07% |
Cipla Ltd. | 5.62% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Dr. Reddy's Laboratories Ltd. | 5.18% |
Medplus Health Services Ltd. | 3.83% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.63% |
Narayana Hrudayalaya Ltd. | 3.55% |
Vijaya Diagnostic Centre Ltd. | 3.32% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.19% |
Divi's Laboratories Ltd. | 7.78% |
Max Healthcare Institute Ltd. | 6.96% |
Lonza Group Ag | 4.76% |
Cipla Ltd. | 4.69% |
Lupin Ltd. | 4.23% |
Mankind Pharma Ltd. | 3.37% |
Abbott India Ltd. | 3.34% |
Fortis Healthcare Ltd. | 3.30% |
Aster DM Healthcare Ltd. | 3.25% |
Fund Manager
Name | Akshay Sharma | Tanmaya Desai |
Start Date | 01 Dec 2022 | 27 Jun 2011 |
Name
Akshay Sharma
Tanmaya Desai
Start Date
01 Dec 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 May 2004 | 04 Jun 1999 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999